Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > CEO and CFO attending bio Pharma symposium

<< Previous

Bullboard Posts

Next >>

Comment by Kd5513on Nov 07, 2023 8:25am

112 Views

Post# 35720990

RE:CEO and CFO attending bio Pharma symposium

I hope it leads to good contacts, but I dont hold my breathe as Paul nor CFO speak with authority or can influence anyone. They speak like Obama parsing words and thinking it over 3X before saying as they are just holding their finger in the air to see which way the wind is blowing.

Also, he's lied staright to our faces for multiple quarters so theres that too.

<< Previous

Bullboard Posts

Next >>

Calibre discovers significant gold in Newfoundland